These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 32682954)
1. Passive immunotherapies targeting Aβ and tau in Alzheimer's disease. Plotkin SS; Cashman NR Neurobiol Dis; 2020 Oct; 144():105010. PubMed ID: 32682954 [TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules. Davtyan H; Zagorski K; Rajapaksha H; Hovakimyan A; Davtyan A; Petrushina I; Kazarian K; Cribbs DH; Petrovsky N; Agadjanyan MG; Ghochikyan A Sci Rep; 2016 Jul; 6():28912. PubMed ID: 27363809 [TBL] [Abstract][Full Text] [Related]
3. Passive Immunotherapies Targeting Amyloid Beta and Tau Oligomers in Alzheimer's Disease. Vander Zanden CM; Chi EY J Pharm Sci; 2020 Jan; 109(1):68-73. PubMed ID: 31647950 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials. Menéndez-González M; Pérez-Piñera P; Martínez-Rivera M; Muñiz AL; Vega JA Curr Pharm Des; 2011; 17(5):508-20. PubMed ID: 21375481 [TBL] [Abstract][Full Text] [Related]
5. Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end? Li Y; Liu Y; Wang Z; Jiang Y Expert Opin Biol Ther; 2013 Nov; 13(11):1515-22. PubMed ID: 24053611 [TBL] [Abstract][Full Text] [Related]
6. Antibody-based therapy in Alzheimer's disease. Pul R; Dodel R; Stangel M Expert Opin Biol Ther; 2011 Mar; 11(3):343-57. PubMed ID: 21261567 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463 [TBL] [Abstract][Full Text] [Related]
18. Tau passive immunization inhibits not only tau but also Aβ pathology. Dai CL; Tung YC; Liu F; Gong CX; Iqbal K Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379 [TBL] [Abstract][Full Text] [Related]
19. Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model. Goñi F; Martá-Ariza M; Herline K; Peyser D; Boutajangout A; Mehta P; Drummond E; Prelli F; Wisniewski T Alzheimers Res Ther; 2018 Jan; 10(1):10. PubMed ID: 29378642 [TBL] [Abstract][Full Text] [Related]
20. Active full-length DNA Aβ Rosenberg RN; Fu M; Lambracht-Washington D Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]